{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:42:20Z","timestamp":1786714940797,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0019-509x.176715","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T08:26:45Z","timestamp":1455870405000},"page":"305","source":"Crossref","is-referenced-by-count":0,"title":["Hematologic, liver enzymes and electrolytes changes in chronic myeloid leukemia after Imatinib medication"],"prefix":"10.4103","volume":"52","author":[{"given":"A","family":"Mohammadbeigi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Moshfeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Nazemizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Mehrzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hajiannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.176715-1","first-page":"53","volume-title":"Survival rate of childhood leukemia in Shiraz, Southern Iran","author":"Amir","year":"2013","journal-title":"Iran J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0101-0107","issn-type":"print"},{"key":"key-10.4103\/0019-509X.176715-2","first-page":"2099","volume-title":"Acute myeloid leukemia: Epidemiology and etiology","author":"Deschler","year":"2006","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.176715-3","first-page":"547","volume-title":"Hematologic and molecular responses to generic imatinib in patients with chronic myeloid leukemia","author":"Razmkhah,","year":"2010","journal-title":"Lab Medicine"},{"key":"key-10.4103\/0019-509X.176715-4","first-page":"4343","volume-title":"Practical management of patients with chronic myeloid leukemia","author":"Cervantes","year":"2011","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.176715-5","first-page":"247","volume-title":"Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries","author":"Mendizabal","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"key-10.4103\/0019-509X.176715-6","first-page":"295","volume-title":"Epidemiology of chronic myeloid leukaemia (CML)","author":"Rohrbacher","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"key-10.4103\/0019-509X.176715-7","first-page":"435","volume-title":"Hematopathologic and cytogenetic findings in Imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience","author":"Braziel","year":"2002","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.176715-8","first-page":"S3","volume-title":"Clinical results with Imatinib in chronic myeloid leukaemia","author":"Crossman","year":"2004","journal-title":"Leuk Res"},{"key":"key-10.4103\/0019-509X.176715-9","first-page":"2640","volume-title":"The development of Imatinib as a therapeutic agent for chronic myeloid leukemia","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"key-10.4103\/0019-509X.176715-10","first-page":"115","volume-title":"Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?","author":"Breccia","year":"2011","journal-title":"Cancer Lett"},{"key":"key-10.4103\/0019-509X.176715-11","first-page":"135","volume-title":"The significance of early, major and stable molecular responses in chronic myeloid leukemia in the Imatinib era","author":"Breccia","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"key-10.4103\/0019-509X.176715-12","first-page":"17","volume-title":"Comparison of effectiveness and safety of Iranian-made versus Indian-made imatinib in treatment of chronic myeloid leukemia","author":"Moshfeghi","year":"2013","journal-title":"Adv Biomed Res","ISSN":"https:\/\/id.crossref.org\/issn\/2277-9175","issn-type":"print"},{"key":"key-10.4103\/0019-509X.176715-13","first-page":"166","volume-title":"Treatment of acute lymphoblastic leukemia","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-509X.176715-14","first-page":"283","volume-title":"Introduction: CML in the Imatinib era","author":"Hehlmann","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"key-10.4103\/0019-509X.176715-15","first-page":"343","volume-title":"Prognostic factors in chronic myeloid leukaemia","author":"Hern\u00e1ndez-Boluda","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"key-10.4103\/0019-509X.176715-16","first-page":"285","volume-title":"CML: A model for targeted therapy","author":"Cilloni","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"key-10.4103\/0019-509X.176715-17","first-page":"1031","volume-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-509X.176715-18","first-page":"994","volume-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","author":"O'Brien","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:23:13Z","timestamp":1786713793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0019-509X.176715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"alternative-id":["176715"],"URL":"https:\/\/doi.org\/10.4103\/0019-509x.176715","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}